of course there is still due with to a suitable strategy for information on medicinal products but this time the european parliament has it should
Of course, there is still much to do with regard to a suitable strategy for information on medicinal products, but fortunately this time the European Parliament has reacted as it always should.
Of course, there is still do with to a suitable strategy for information on medicinal products, but this time the European Parliament has it should.